We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Glia-dependent TGF-β signaling, acting independently of the TH17 pathway, is critical for initiation of murine autoimmune encephalomyelitis.
- Authors
Jian Luo; Ho, Peggy P.; Buckwalter, Marion S.; Hsu, Tiffany; Lee, Lowen Y.; Hui Zhang; Dae-Kee Kim; Seong-Jin Kim; Gambhir, Sanjiv S.; Steinman, Lawrence; Wyss-Coray, Tony
- Abstract
Autoimmune encephalomyelitis, a mouse model for multiple sclerosis, is characterized by the activation of immune cells, demyelination of axons in the CNS, and paralysis. We found that TGF-β1 synthesis in glial cells and TGF-β-induced signaling in the CNS were activated several days before the onset of paralysis in mice with autoimmune encephalomyelitis. While early production of TGF-β1 was observed in glial cells TGF-β signaling was activated in neurons and later in infiltrating T cells in inflammatory lesions. Systemic treatment with a pharmacological inhibitor of TGF-β signaling ameliorated the paralytic disease and reduced the accumulation of pathogenic T cells and expression of IL-6 in the CNS. Priming of peripheral T cells was not altered, nor was the generation of TH17 cells, indicating that this effect was directed within the brain, yet affected the immune system. These results suggest that early production of TGF-β1 in the CNS creates a permissive and dangerous environment for the initiation of autoimmune inflammation, providing a rare example of the brain modulating the immune system. Importantly, inhibition of TGF-β signaling may have benefits in the treatment of the acute phase of autoimmune CNS inflammation.
- Publication
Journal of Clinical Investigation, 2007, Vol 117, Issue 11, p3306
- ISSN
0021-9738
- Publication type
Academic Journal
- DOI
10.1172/JCI31763